Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 140 shares at $88.46 ($12K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Open-market sale of $12k LGND by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |